The National Cancer Research Institute (NCRI) Conference takes place at the Scottish Event Campus in Glasgow on 4-6 November 2018.
It's the UK’s largest conference to showcase advances in cancer research – providing a platform for researchers, clinicians and industry representatives to discuss and present their latest findings.
As one of 19 partner organisations, Macmillan is delighted to attend the conference to promote how we prioritise, conduct and share our research – which delivers real impact for people living with cancer.
2018 Conference programme
This year, the NCRI has created an interdisciplinary programme in five streams:
- Cancer discovery and underpinning research
- Early detection
- Diagnosis and prognosis
- Treatment and cancer control: living with and beyond cancer outcomes.
How is Macmillan taking part?
Macmillan will showcase research throughout the conference, including:
- Sponsoring a session on 'The reality of cancer treatment consequences', co-chaired by Diana Greenfield – a Macmillan Consultant Nurse in Late Effects, who also sits on the Macmillan Research Advisory Panel.
- Presenting our approach to system-wide change in health services, with findings from Improving the Cancer Journey (ICJ), including how artificial intelligence and interactive visualisation technology can improve service provision with data analysis.
- An Igloo Session to outline how and why our support model works, and the impact it has for people living with cancer in Glasgow. A person living with cancer, who has used the service, will also share their experiences.
Macmillan-led and funded research
We will share research led by Macmillan and research funded by the Macmillan Research Grants Scheme. This includes e-posters, physical posters and presentations, with:
- Analysis of the Cancer Workforce Census, which collected data on the size, distribution and support needs of the cancer workforce in England.
- Joint analysis with NCRAS on the number of people living with treatable but not curable cancer.
- Joint research with Public Health Wales into the prevalence and outcomes for people with cancer and other health conditions.
- Making the case for prehabilitation in cancer care.
- Three pieces of research from the Scottish Routes from Diagnosis framework, investigating:
- Palliative opioid prescribing using patient-level community prescribing data
- Common comorbidities in patients diagnosed with cancer
- Survival differences in patients with multiple cancer diagnoses.
- The outcomes of completing the Macmillan Quality Toolkit in Scottish GP practices.
- Macmillan-funded research with the University of Southampton, including the latest findings from the ColoREctal Well-being (CREW) and HORIZONS studies.